Ligand validation:1WS5

MMA: methyl alpha-D-mannopyranoside

MMA is a Ligand Of Interest in 1WS5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1WS5_MMA_A_501	80%	4%	0.1	0.949	1.09	4.68	1	2	0	0	100%	1
1WS5_MMA_G_504	74%	3%	0.104	0.934	1.14	4.82	1	2	0	0	100%	1
1WS5_MMA_C_502	71%	3%	0.118	0.937	1.16	4.77	1	2	0	0	100%	1
1WS5_MMA_E_503	62%	3%	0.115	0.906	1.06	4.77	1	2	0	0	100%	1
1KUJ_MMA_A_501	90%	36%	0.069	0.951	1.36	1.16	1	1	0	0	100%	1
2BV4_MMA_A_400	99%	50%	0.058	0.99	0.67	1.24	-	-	0	0	100%	0.9769
3ZDV_MMA_A_201	99%	58%	0.042	0.985	0.63	0.96	-	1	0	0	92%	0.9231
1MVQ_MMA_A_237	98%	52%	0.058	0.981	0.96	0.9	-	1	0	0	100%	1
2JDY_MMA_D_1115	98%	59%	0.059	0.978	0.7	0.87	-	-	0	0	100%	1
2VNV_MMA_A_201	98%	51%	0.06	0.979	1.01	0.9	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.